Stay updated on Pembrolizumab in Newly Diagnosed Glioblastoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Newly Diagnosed Glioblastoma Clinical Trial page.

Latest updates to the Pembrolizumab in Newly Diagnosed Glioblastoma Clinical Trial page
- Check2 days agoChange DetectedThe page footer software revision was updated from **v3.5.2** to **v3.5.3**.SummaryDifference0.1%

- Check10 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check38 days agoChange DetectedRevision indicator updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check45 days agoChange DetectedThe page shows an updated revision version from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check74 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2 on the page. It appears to be a minor site version update with no changes to study data or user-facing functionality.SummaryDifference0.1%

- Check81 days agoChange DetectedThe change updates the page revision label from v3.4.0 to v3.4.1, with no changes to study content or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab in Newly Diagnosed Glioblastoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Newly Diagnosed Glioblastoma Clinical Trial page.